+416,083.7%
NVDA vs INCY
+736.7%
+415,347.0%
-89.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | INCY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | -0.6% | -3.5% | -4.0% |
| 7D | -12.6% | -1.3% | -11.3% | -12.3% |
| 30D | -27.1% | +6.4% | -33.4% | -28.2% |
| 3M | -30.6% | +0.1% | -30.7% | -30.8% |
| 6M | -30.5% | +26.2% | -56.7% | -35.0% |
| YTD | -16.1% | +21.8% | -37.9% | -20.9% |
| 1Y | -17.7% | +15.5% | -33.2% | -21.6% |
| 3Y | +216.5% | +122.8% | +93.7% | +150.7% |
| 5Y | +419.2% | +83.0% | +336.2% | +331.0% |
| 10Y | +6,845.9% | +19.4% | +6,826.5% | +6,038.9% |
| All | +416,083.7% | +736.7% | +415,347.0% | +135,715.3% |
Cumulative growth
Daily Returns
Daily percentage return beside INCY.
Daily Out/Under-Performance
Portfolio return minus INCY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INCY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded INCY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling